Food Noise Took Center Stage at ObesityWeek: What Novo's Data on 33,000-Plus Patients and Lilly's Eloralintide Interviews Actually Show

Both big GLP-1 makers brought food noise data to ObesityWeek. The numbers are real, but they are self-reported and have no comparison group. Here is how to read them heading into the holidays.

Order Meals — View This Week's Menu

By Lew Kizer — 2026-11-19 — Health & Nutrition

The short answer

At ObesityWeek 2026, Novo Nordisk reported that food noise scores fell in two real-world studies of Ro telehealth patients: by 0.72 points on a 1-to-5 scale at six months on the Wegovy shot (26,213 patients) and by about 25%, from 2.8 to 2.1, at three months on the Wegovy pill (7,669 patients). Lilly said 52% of people in an eloralintide trial reported less food noise in exit interviews. All of this is self-reported, with no comparison group, and eloralintide is not approved.

Key facts

  • Novo presented two retrospective studies on Nov. 14, 2026, using de-identified data from the Ro telehealth platform.
  • Food noise was measured with the seven-item RAID-FN questionnaire; each item is scored 1 to 5, with 5 the most intense.
  • SIGNAL (Wegovy shot): 26,213 adults new to treatment. Average score started at 2.72 and fell 0.42 points by month 1 and 0.72 points by month 6; most of the drop came in the first three months.
  • OCTANE (Wegovy pill): 7,669 adults. Among 6,180 with scores at both points, the average fell from 2.8 to 2.1 at three months, about 25%.
  • In OCTANE, 86.4% reported at least one improvement at three months; 51.6% said they were eating healthier.
  • Lilly said 74% of eloralintide Phase 2 participants reported fewer cravings, especially for sugary foods, and 52% reported less food noise at 48 weeks. Lilly gave no sample size.
  • Both studies required people to stay on treatment, and Novo's release says real-world studies cannot determine causality.

KINGSPORT, Tenn., Nov. 19, 2026 — "Food noise" has gone from a social media phrase to a research topic, and at ObesityWeek, which ended Tuesday, both big GLP-1 makers brought numbers. Novo Nordisk reported food noise scores in more than 33,000 telehealth patients on the Wegovy shot or pill. Eli Lilly reported what people in an eloralintide trial said about cravings. Our ObesityWeek preview said to watch for this. Here is what came out, and how much weight to give it.

This article reports medical news and is not medical advice. SmashMeals is a food company, not a medical provider, and is not affiliated with the companies or researchers named here. Talk with your prescriber before you start, stop, switch or change any medicine.

Novo's two studies

Both studies used de-identified records from Ro, a telehealth company. Food noise was scored with the RAID-FN, a seven-item questionnaire where each answer runs from 1 to 5 and 5 means the most intense food noise.

SIGNAL, the Wegovy shot: 26,213 adults new to weight medicines, followed up to six months. The average score started at 2.72. It fell 0.42 points by month one and 0.72 points by month six, with most of the drop in the first three months.

OCTANE, the Wegovy pill: 7,669 adults who started the pill in January and February 2026. Among 6,180 people with scores at both points, the average fell from 2.8 to 2.1 over three months, about 25%. At three months, 86.4% reported at least one improvement: 67.5% said clothes fit better and 51.6% said they were eating healthier.

"Patients at our center often describe persistent and intrusive thoughts about food," said Dr. Louis Aronne of Weill Cornell Medicine, a co-author. He said further research can help clarify what the findings mean clinically.

Lilly's numbers

Lilly's release said that in exit interviews at 48 weeks, 74% of participants in a Phase 2 eloralintide trial reported fewer cravings, especially for sugary foods, and 52% reported less food noise. Among those who drank alcohol at the start, 41% said they drank less. Lilly did not give a sample size, and eloralintide is not approved.

Lilly also reported a survey on Foundayo, its daily GLP-1 pill, in which 96% to 98% of participants said it was simple and easy to use and about 40% took it in the afternoon, evening or at bedtime. "Obesity care is about more than numbers on the scale," said Kenneth Custer, president of Lilly Cardiometabolic Health.

How to read these results

These are company-sponsored, self-reported results with no comparison group. Novo's studies only counted people who stayed on treatment, which can make results look better than they would for everyone who starts. Novo's own release lists those limits and says real-world studies "cannot determine causality." Michelle Skinner Moore of Novo called food noise "an emerging area of research." None of these results is a reason to start, stop or switch a medicine.

Food noise and the holiday table

Thanksgiving is a week away. Some people whose appetite has quieted find the harder part is not overeating but filling up on a few bites and missing protein. A smaller plate with turkey or ham first is a common plan. Our gluten-free Thanksgiving menu sells items one at a time, so you can order what you will actually eat. Thanksgiving shipping orders closed Nov. 18; local pickup orders are open through Saturday, Nov. 21, 2026. The Thanksgiving page has current items and prices.

For the weeks around the holiday, our GLP-1 meal planning page, the illustrative 7-day GLP-1 meal plan and our Wegovy meal plan cover eating with a smaller appetite. None of it replaces advice from your care team.

“You don't have to figure out the macros. You don't have to wonder if the portions are right. We've already done that work. All you have to do is eat.” — Lew Kizer, Founder, SmashMeals

Pick up locally or order for shipping; checkout confirms timing. See this week's meals.

Commentary, not medical advice

The SmashMeals perspective

When food noise quiets down, people still have to decide what to eat, and they often want less of it. That is where a portioned meal helps: the decision is already made, the protein is already there, and the nutrition is posted. We cook those meals in a 100% gluten-free kitchen in Kingsport.

Frequently asked questions

What is food noise?

Novo's release defines it as persistent, intrusive and unwanted thoughts about food. It is a newer research topic, and researchers are still working out how best to measure it.

Do these studies prove Wegovy reduces food noise?

No. They looked back at patient questionnaires with no comparison group, and only people who stayed on treatment were included. Novo's release says real-world studies cannot determine causality. The findings are associations.

How big was the change?

On the Wegovy pill, the average score went from 2.8 to 2.1 on a 1-to-5 scale over three months, about a 25% drop. On the shot, it fell 0.72 points over six months from a starting average of 2.72. Researchers say more work is needed on what size of change matters to patients.

What is eloralintide?

It is an investigational amylin-type medicine from Eli Lilly, being studied alone and with tirzepatide. It is not approved. The food noise figures come from interviews with trial participants as they finished the study.

Does less food noise mean I can skip planning holiday meals?

Not really. A quieter appetite can make it easier to undereat protein or skip meals altogether. Many people do better with a simple plan for a smaller plate. Ask your care team what fits you.

Sources and credits

Follow the original sources for context and verification. A reference is not an endorsement of SmashMeals.

More SmashMeals news

Order Meals — View This Week's Menu